Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
439 studies found for:    Open Studies | "Tissue Donors"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Tissue Donors"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
Conditions: For Donors:;   Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling;   For Recipients:;   Acute Myelogenous Leukemia (AML);   Acute Lymphoblastic Leukemia (ALL);   Myelodysplastic Syndrome (MDS);   Chronic Myelogenous Leukemia (CML);   Non-Hodgkins Lymphoma (NHL);   Hodgkins Disease (HD);   Chronic Lymphocytic Leukemia (CLL)
Interventions: Drug: CDX-301;   Drug: CDX-301 and plerixafor
2 Recruiting Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation
Conditions: Deceased Donor Kidney Transplantation;   Living Donor Kidney Transplantation
Intervention: Procedure: kidney transplantation, living or deceased donor
3 Recruiting Deceased Donor Biomarkers and Recipient Outcomes
Conditions: Deceased Donor Kidney Transplant;   Acute Kidney Injury;   Delayed Graft Function;   End Stage Renal Disease;   Graft Failure
Intervention:
4 Recruiting Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures
Condition: Normal Donors
Intervention:
5 Not yet recruiting Robotic Single Port Donor Nephrectomy
Conditions: Renal Transplant Donor of Left Kidney;   Donor Nephrectomy;   Robotic Surgery;   Single-port
Intervention: Device: da Vinci® Single-Site™
6 Recruiting Motivating Type O- Blood Donors to Return
Condition: Blood Donors
Intervention: Behavioral: Motivational Interview and Implementation Intention
7 Recruiting Rx Milk Study of Donor Milk Supplementation to Improve Breastfeeding Outcomes
Conditions: Breastfeeding Duration;   Exclusive Breastfeeding;   Donor Milk Supplementation
Intervention: Other: Donor Milk
8 Not yet recruiting GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study
Condition: Normal Oocyte Donors
Intervention: Drug: Triptorelin
9 Recruiting Evaluation of Post-traumatic Stress Among the Nearest Relatives of Brain-dead Organ Donors
Conditions: Stress Disorders, Post-Traumatic;   Tissue Donors;   Tissue and Organ Procurement
Intervention: Other: Questionnaires and interview
10 Recruiting Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment
Conditions: Late Complication From Skin Graft;   Infection of Skin Donor Site;   Impaired Wound Healing;   Pain, Intractable
Intervention: Device: Sericin scaffold
11 Recruiting Hepatitis B Antigen Kidney Graft Into Protective Level Hepatitis B Antibody Recipients
Conditions: HBsAg(+) Donor Kidney Allograft;   HBsAg(-) Donor Kidney Allograft
Intervention: Biological: HBsAg positive kidney allograft donor
12 Unknown  Multi-Center, Prospective, Randomized, Comparison of AWBAT™-D vs. Xeroform™ or Glucan II™ for Treatment of Donor Sites in Burn Surgery
Condition: Treatment of Donor Site Burns
Intervention: Device: AWBAT™-D and XEROFORM™ OR GLUCAN II™ dressings
13 Recruiting Vasodilator-induced Hypovolemia in Living Liver Donors
Conditions: CVP and SVV During Living Donor Hepatectomy;   Surgical Field Grade (Condition of Surgical Field; Bleeding, Tension of the IVC)
Intervention: Procedure: vasodilator induced hypovolemia
14 Recruiting CD34+ Cell Enriched and T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Mismatched Related Donors or Borderline Organ Function
Conditions: Subjects With Malignant and Non-malignant Diseases Who Are Eligible for a Hematopoietic Stem Cell Transplant;   Subjects Who Require Alternative Donors for Stem Cell Transplant
Intervention: Device: CliniMACS CD34+ cell enrichment and T-cell depletion
15 Unknown  Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor
Conditions: Renal Transplant Patients;   Recipients of a Kidney From a Non-Heart-Beating Donor
Intervention: Drug: ATG Fresenius
16 Unknown  Dengue Seroprevalence Study in Blood Donors in the French West Indies
Conditions: Blood Donors;   Dengue
Intervention: Other: Biological sample collection
17 Recruiting Improving White Blood Cell Collection From Healthy Donors
Conditions: Blood Donor;   Leukocyte Transfusion;   Granulocyte Colony-Stimulation Factor;   Blood Component Removal
Interventions: Drug: Filgrastim (G-CSF);   Drug: Dexamethasone
18 Recruiting Conventional Laparoscopic Versus Laparoendoscopic Single Site Donor Nephrectomy in Living Donor Kidney Transplantation
Conditions: Living Donors;   Nephrectomy;   Kidney Transplantation;   Surgery, Laparoscopic
Interventions: Procedure: Laparoendoscopic single site donor nephrectomy;   Procedure: Conventional laparoscopic donor nephrectomy
19 Recruiting Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation
Conditions: Disorder of Transplanted Kidney;   Donor Specific Alloantibodies
Interventions: Drug: Bortezomib;   Other: Standard posttransplant treatment
20 Recruiting A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
Conditions: For Donors:;   Related Donors Donating PBSC to a Family Member;   For Recipients:;   Acute Myelogenous Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome;   Chronic Myelogenous Leukemia;   Non-Hodgkin's Lymphoma;   Hodgkin's Disease;   Chronic Lymphocytic Leukemia
Intervention: Drug: Plerixafor

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years